000			02242 a2200649 4500
005			20250516090020.0
264		0	_c20150414
008			201504s 0 0 eng d
022			_a1592-8721
024	7		_a10.3324/haematol.2011.059246 _2doi
040			_aNLM _beng _cNLM
100	1		_aJäger, Ulrich
245	0	0	_aRituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. _h[electronic resource]
260			_bHaematologica _cSep 2012
300			_a1431-8 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xblood
650	0	4	_aBone Marrow _xdrug effects
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitoxantrone _xadministration & dosage
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPilot Projects
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aRemission Induction
650	0	4	_aRituximab
650	0	4	_aSex Factors
650	0	4	_aSurvival Rate
650	0	4	_aTissue Distribution
650	0	4	_aVidarabine _xadministration & dosage
700	1		_aFridrik, Michael
700	1		_aZeitlinger, Markus
700	1		_aHeintel, Daniel
700	1		_aHopfinger, Georg
700	1		_aBurgstaller, Sonja
700	1		_aMannhalter, Christine
700	1		_aOberaigner, Wilhelm
700	1		_aPorpaczy, Edit
700	1		_aSkrabs, Cathrin
700	1		_aEinberger, Christine
700	1		_aDrach, Johannes
700	1		_aRaderer, Markus
700	1		_aGaiger, Alexander
700	1		_aPutman, Monique
700	1		_aGreil, Richard
773	0		_tHaematologica _gvol. 97 _gno. 9 _gp. 1431-8
856	4	0	_uhttps://doi.org/10.3324/haematol.2011.059246 _zAvailable from publisher's website
999			_c21711053 _d21711053